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Abstract: Protein kinase RNA activated (PKR) is a crucial mediator of anti-viral responses 25 
but is reported to be activated by multiple non-viral stimuli. However, mechanisms 26 
underlying PKR activation, particularly in response to bacterial infection, remain poorly 27 
understood. We have investigated mechanisms of PKR activation in human primary 28 
monocyte-derived dendritic cells in response to infection by Chlamydia trachomatis. 29 
Infection resulted in potent activation of PKR that was dependent on TLR4 and MyD88 30 
signalling. NADPH oxidase was dispensable for activation of PKR as cells from chronic 31 
granulomatous disease (CGD) patients, or mice that lack NADPH oxidase activity, had 32 
equivalent or elevated PKR activation. Significantly, stimulation of cells with endoplasmic 33 
reticulum (ER) stress-inducing agents resulted in potent activation of PKR that was blocked 34 
by an inhibitor of IRE1α RNAse activity. Crucially, infection resulted in robust IRE1α 35 
RNAse activity that was dependent on TLR4 signalling whilst inhibition of IRE1α RNAse 36 
activity prevented PKR activation. Finally, we demonstrate that TLR4/IRE1α mediated PKR 37 
activation is required for the enhancement of interferon-β production following C. 38 
trachomatis infection. Thus, we provide evidence of a novel mechanism of PKR activation 39 
requiring ER stress signalling that occurs as a consequence of TLR4 stimulation during 40 
bacterial infection and contributes to inflammatory responses. 41 
Key words: PKR; ER stress; Chlamydia 42 
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1. Introduction 50 
Protein kinase RNA activated (PKR) was originally identified as a cytosolic kinase that was 51 
activated by double stranded RNA (dsRNA) that could terminate protein translation by acting 52 
as an eIF2α kinase [1-3]. PKR activation occurs as a consequence of auto phosphorylation at 53 
several serine and threonine residues following the binding of dsRNA within the N’terminus 54 
and phosphorylation of Thr451 within the activatory domain is critical for PKR function [4]. 55 
The role of PKR during viral infection is well documented. However, PKR is also activated 56 
during Toll Like Receptor (TLR) signalling, independent of dsRNA, and regulates 57 
inflammatory responses and cell death [5-6]. Additionally, PKR has been reported to be 58 
necessary for NLRP3 and NLRC4 inflammasome activation [7] although these findings have 59 
proved controversial [8]. Furthermore, sterile agonists such as cholesterol, palmitic acid [9-10] 60 
and the endoplasmic reticulum (ER) stress-inducing agents tunicamycin and thapsigargin can 61 
all induce PKR activation [10-11]. These data indicate that in addition to its function during 62 
viral infection, PKR also responds to a variety of stimuli such as bacterial infection, and to 63 
metabolic or ER stress. However, despite overwhelming evidence that PKR is activated by a 64 
wide range of stimuli, the mechanisms of how this occurs, particularly as a result of TLR 65 
stimulation and bacterial infection, are poorly understood. We have investigated mechanisms 66 
of PKR activation in response to a common intracellular bacterial infection, Chlamydia 67 
trachomatis, and the role that TLR4, ER stress and the NADPH oxidase system play in the 68 
process. 69 
 70 
 71 
 72 
 73 
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2. Methods 75 
2.1 Reagents 76 
Ultra pure LPS (E. coli) and Poly I:C were obtained from Invivogen (France), peptidoglycan 77 
(B.  subtilis) was obtained from Sigma (U.K.), and curdlan (A. faecalis) was obtained from 78 
Wako (U.S.A). Anti-phospho Thr451-PKR was obtained from Millipore (U.K.), anti-PKR 79 
(D20) from SantaCruz (U.S.A) and anti-actin from Abcam (U.K.). The IRE1α inhibitor (4µ8c) 80 
was obtained from Tocris (U.K.), the PKR inhibitor (C16) from Calbiochem (Germany) and 81 
the PERK inhibitor (GSK PERK inhibitor-D3) from Toronto Research Chemicals (Canada). 82 
Anti-TLR4 blocking antibody, inhibitory peptides for MyD88 and TRIF were all from 83 
Invivogen (France). 84 
 85 
2.2 Cell culture  86 
Human monocyte-derived dendritic cells (mDC) were cultured from monocytes obtained 87 
from apheresis transfusion cones (National transfusion service U.K.) by ficoll density 88 
centrifugation and positive CD14 selection using micro-beads (Miltenyi, U.K.) to achieve 89 
monocyte cultures that were >90% pure. Monocytes were cultured for 6-days in RPMI1640 90 
containing 5% FCS, 20ng/ml GM-CSF (Gibco, U.K.) and 4ng/ml IL-4 (BD Pharmingen, 91 
U.K.). Murine bone marrow derived macrophages (BMDM) were isolated from the femurs of 92 
littermate wild type (cybb+/+ or pkr+/+),  gp91 phox deficient (cybb-/-) or PKR deficient (pkr-/-) 93 
C57BL6 mice and cultured for 7-days in RPMI1640 containing 10% FCS and supplemented 94 
with 5% L929 conditioned media. Wild type (gcn2+/+) or GCN2 deficient (gcn2-/-) mouse 95 
embryonic fibroblasts (MEF’s) were cultured in DMEM containing10% FCS and 96 
supplemented with 55µM β-mercaptoethanol.  97 
 98 
 99 
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2.3 Cell stimulations and infections 100 
BMDM or mDC were harvested by scraping and plated at 5x105 cells/well of a 24-well plate 101 
(Costar). Human mDC were stimulated for 4-hours with either 1µg/ml LPS, 10µg/ml 102 
peptidoglycan (PGN), 25µg/ml Poly I:C (PIC), or 100µg/ml Curdlan (CUR). BMDM or 103 
human mDC were infected with Chlamydia trachomatis at a multiplicity of infection (MOI) 104 
of 20 (unless stated otherwise) for indicated times. Attenuated C. trachomatis was prepared 105 
by gamma irradiation or heat inactivation. Where inhibitors were used, cells were pre-treated 106 
at least 1hr prior to cell stimulation or infection with the exception of the MyD88 and TRIF 107 
inhibitory peptides that were used at least 4hrs prior to stimulation or infection. MEF’s were 108 
plated at 5x105 cells/well of a 6-well plate (Corning) and infected with the murine pathogen 109 
Chlamydia muridarum or Chlamydia trachomatis at MOI=10 followed by centrifugation at 110 
2000xG for 40 minutes to aid infectivity.  111 
 112 
2.4 Preparation of cytoplasmic lysates for immunoblotting 113 
BMDM and mDC were washed once in cold PBS. The cells were then lysed on ice in 300µl 114 
of ice cold cytoplasmic lysis buffer (10mM HEPES, 50mM NaCl, 0.5M Sucrose, 0.1Mm 115 
EDTA, 0.5% v/v Triton X-100, 10mM Tetrasodium pyrophosphate, 17.5mM β-116 
glycerophosphate and one complete mini-protease inhibitor cocktail tablet). After lysis the 117 
cytoplasmic extract was frozen at -20ºC overnight before thawing to aid cell lysis. The lysate 118 
was then centrifuged 15000xG for 15 minutes at 4ºC and the supernatant retained. Protein 119 
quantification of the lysates was carried out by Bradford assay (Thermo, U.K.). 120 
 121 
 122 
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2.5 SDS PAGE and Immunoblotting 125 
Equal amounts of cytoplasmic protein lysate were mixed with 5x gel loading buffer (10% w/v 126 
SDS, 0.3M TRIS-HCL, 25% v/v β-Mercaptoethanol and glycerol) and boiled for 10 minutes. 127 
The samples were then loaded on to pre-cast gradient (4-20%) acrylamide gels (BioRad, U.K.) 128 
and run for 2hrs at constant 30mA. After SDS PAGE, the separated protein was transferred to 129 
PVDF membrane using the BioRad midi system and Turbo Transblot (BioRad, U.K.).  PVDF 130 
membranes were then blocked for 1hr in 5% w/v milk protein in TBS. Blocked membranes 131 
were then incubated with specific antibodies at 1:1000 dilution (p-PKR and PKR) or 1:5000 132 
(Actin)  in blocking buffer overnight at 4ºC with agitation. Detection of specific proteins was 133 
achieved by incubating the membranes in specific HRP conjugated secondary antibodies 134 
(eBioscience, U.K.) (1:2000 dilution in blocking buffer) for 1hr at room temperature. 135 
Membranes were washed 3 times in TBS 0.1v/v Tween and proteins detected using ECL 136 
(PerkinElmer, U.K.) and HyperFilm (Amersham, U.K.). 137 
 138 
2.6 RNA extraction cDNA synthesis and qPCR 139 
Total RNA was prepared as per the manufacturer’s instructions (Bioline). For analysis of 140 
XBP1 splicing, total RNA was subjected to cDNA synthesis using Superscript cDNA 141 
synthesis kit (LifeTechnologies) as per the manufacturer’s instructions. The resultant cDNA 142 
was then subjected to qPCR using SYBR Green (Anachem, U.K.) specific primers for spliced 143 
XBP1 (forward: 5’-TGCTGAGTCCGCAGCAGGTG-3’ reverse: 5’-144 
GCTGGCAGGCTCTGGGGAAG-3’) and normalised to HPRT expression (forward: 5’-145 
GACACTGGCAAAACAATG-3’ reverse: 5’-ACAAAGTCTGGCTTATATCC-3’. For 146 
CHOP and interferon-β expression, qRT-PCR was employed using commercial probe/primer 147 
sets (LifeTechnologies) and analysed using the Taqman ‘one-step’ system. 148 
 149 
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2.7 ELISA of Interferon-β in BMDM supernatants 150 
Wild type (PKR+/+) and PKR knock out (PKR-/-) BMDM were plated at 1x105 cells per well 151 
of a 96-well plate. Cells were infected with C. trachomatis at an MOI of 20 for 24hrs. Plates 152 
were centrifuged at 2000xG for 5-minutes and the supernatants harvested. ELISA was 153 
performed on the supernatants to analyse interferon-β secretion using an in-house assay 154 
utilising capture antibody (monoclonal rat anti-mouse IFNβ IgG1; Santa Cruz: sc57201), 155 
detection antibody (polyclonal rabbit anti-mouse IFNβ; RnD Systems: 32400-1) and 156 
secondary antibody (goat anti-rabbit-HRP; Cell Signalling Technology 7074). Interferon 157 
standard curve was prepared using recombinant mouse interferon-β (Interferon Source; 158 
U.S.A). 159 
 160 
2.8 Statistical analysis 161 
Differences between multiple data sets were analysed using 1-Way ANOVA with Tukey’s or 162 
Dunnet’s post test correction where appropriate. Differences between two data sets were 163 
analysed using Student’s t-test. Differences between wild type and knock out data sets were 164 
analysed using 2-Way ANOVA. p values of <0.05 were deemed significant.  165 
 166 
 167 
3. Results 168 
 169 
3.1 Agonists of Pathogen Recognition Receptors or Chlamydia infection are potent activators 170 
of PKR in human mDC  171 
Previous work demonstrated that TLR4 or TLR2 agonists are potent inducers of PKR 172 
phosphorylation in murine alveolar macrophages [5]. However, little is known about 173 
activation of PKR in primary human mDC, we therefore examined whether PKR activation 174 
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occurred in response to stimulation of specific PRR’s (figure 1A). Stimulation of mDC with 175 
agonists of TLR4 (LPS), TLR2 (Peptidoglycan), TLR3 (Poly I:C) or Dectin-1 (Curdlan) all 176 
induced a significant increase in PKR phosphorylation suggesting that PKR activation is a 177 
universal response to PRR ligation in mDC. We next investigated whether PKR is activated in 178 
response to infection with the intracellular bacterial pathogen Chlamydia trachomatis. To 179 
examine this, we infected human mDC at different multiplicities of infection (MOI) ranging 180 
from a ratio of 20 infectious units (IFU) per cell down to a ratio of 1:1 (fig 1B).  We found 181 
that higher MOI’s of 10-20 IFU’s per cell induced the greatest increase in PKR 182 
phosphorylation compared to the non-infected control and that this was reduced at lower 183 
MOI’s. We therefore conducted all future Chlamydia infection experiments at an MOI of 20.  184 
We next investigated whether intracellular replication of C. trachomatis was a requirement 185 
for PKR activation. To do this, we infected mDC with live and heat-treated or gamma-186 
irradiated attenuated C. trachomatis (which fail to replicate intracellularly in Hela cells), or 187 
stimulated cells with LPS or heat-treated LPS as a control (figure 1C). Both heat-treated and 188 
gamma-irradiated attenuated C. trachomatis were able to stimulate PKR activation in mDC to 189 
the same extent as live C. trachomatis, indicating that replication of C. trachomatis 190 
intracellularly, or the production by the Chlamydiae of a heat-labile pathogen associated 191 
molecular pattern (PAMP), were not responsible for the activation of PKR. Heat-treating LPS 192 
had no effect on its ability to activate PKR confirming its heat stability and suggests that C. 193 
trachomatis LPS is the likely PAMP required for PKR activation. It is unlikely to be 194 
Chlamydia hsp60, which has previously been implicated in TLR4 signalling during 195 
Chlamydia infection [13]. 196 
FIG 1. 197 
 198 
 199 
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3.2 Chlamydia activates PKR through TLR4 and MyD88 signalling in contrast to E. coli LPS 200 
which required TLR4 and TRIF 201 
Chlamydiae sp infection or stimulation with chlamydial heat shock proteins have previously 202 
been reported to activate TLR2 and TLR4 signalling to initiate inflammatory responses and 203 
cell death [12-13] [14-17]. C.  trachomatis is a Gram negative organism and as such contains 204 
LPS in its outer membrane [18]; given that  heat-killed C. trachomatis could induce PKR 205 
activation, suggesting that heat stable LPS might be responsible, we tested the hypothesis that 206 
TLR4 was the pathogen recognition receptor (PRR) required. To do this, we infected mDC 207 
with C. trachomatis (figure 2A) or, as a control, stimulated mDC with LPS (figure 2B), in the 208 
presence of a TLR4 blocking antibody or the TLR4 antagonist; lipid IVa. Blocking TLR4 209 
signalling by either of these means potently inhibited C. trachomatis-induced PKR activation 210 
indicating a requirement for TLR4 in the induction of PKR activation in response to infection. 211 
TLR4 signalling can utilise two adaptor proteins, MyD88 and TRIF [19-20], and a previous 212 
study demonstrated that activation of PKR in response to LPS was TRIF-dependent [6]. We 213 
therefore tested the hypothesis that C. trachomatis-induced PKR activation also required 214 
TRIF. To do this, we infected mDC with C. trachomatis (figure 2C) or, as a control, 215 
stimulated the cells with LPS (figure 2D), in the presence of MyD88 or TRIF inhibitory 216 
peptides, or a control peptide (CP). Compared to the control peptide (CP), LPS-induced PKR 217 
phosphorylation was entirely TRIF-dependent.  Unexpectedly however, infection-induced 218 
PKR phosphorylation required MyD88 but was unaffected by TRIF inhibition compared to 219 
the control peptide (CP). Thus, there are distinct differences in the use of the adaptor proteins 220 
during C. trachomatis infection or stimulation with E. coli-derived LPS that contribute to 221 
PKR activation. 222 
FIG 2. 223 
 224 
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3.3 Infection induced PKR activation is independent of NADPH oxidase 225 
We next investigated what signals might be required in addition to TLR4 signalling to induce 226 
PKR activation. The mammalian NADPH oxidase system (NOX) is an important component 227 
of cellular host defence against microbial pathogens.  Deletion or mutation of NOX2 results 228 
in immunodeficiency characterised by recurrent bacterial infection as observed in patients 229 
suffering with chronic granulomatous disease (CGD) [21-22].  ROS signalling is known to be 230 
involved in many aspects of innate responses to microbes and sterile inflammation. Indeed, 231 
NOX-derived ROS have been implicated in the activation of PKR in response to cholesterol 232 
loading [9]. We therefore examined whether NADPH oxidase was required for PKR 233 
activation in response to infection in mDC and murine BMDM. Infection of BMDM (figure 234 
3A) from wild type (Cybb+/+) or NOX deficient mice (Cybb-/-) or mDC (figure 3B) from CGD 235 
patients who lack a functional NADPH oxidase system. Infection of NADPH oxidase 236 
deficient cells resulted in equivalent or even elevated (in the case of  human mDC) PKR 237 
phosphorylation compared to healthy controls, indicating that NADPH oxidase is not required 238 
for chlamydia induced PKR activation and differs from cholesterol. However, we cannot rule 239 
out the possibility that ROS derived from other sources, such as the mitochondria, are 240 
involved in the activation of PKR in response to C. trachomatis infection. 241 
FIG 3. 242 
 243 
3.4 The Endoplasmic Reticulum stress-inducing chemicals Tunicamycin and Thapsigargin 244 
induce PKR activation that is blocked by an inhibitor of IRE1α RNAse activity 245 
The unfolded protein response (UPR) is a physiological mechanism that is initiated when the 246 
protein folding capacity of the ER is exceeded leading to ER stress [23]. Three ER sentinel 247 
proteins regulate the UPR: PERK, IRE1 and ATF6 which activate specific and shared target 248 
genes in response to ER stress resulting in either restoration of homeostasis or induction of 249 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 11
cell death [23]. Additionally, activation of ER stress signalling pathways has been shown to 250 
be crucial for certain inflammatory responses resulting from TLR signalling and bacterial 251 
infections [12, 24-25]. Significantly, ER stress-inducing agents are known to activate PKR 252 
[10-11]. We therefore examined the hypothesis that ER stress signalling could activate PKR 253 
in mDC using chemical inducers of ER stress prior to examining the effects of Chlamydia 254 
infection. Stimulation of mDC with either tunicamycin or thapsigargin (figure 4A) resulted in 255 
potent phosphorylation of PKR, albeit with differing kinetics, confirming that ER stress leads 256 
to PKR activation. We next tested the hypothesis that the ER stress sentinels IRE1α or PERK 257 
regulated the mechanism of PKR activation. To do this, we utilised the well characterised 258 
inhibitors 4µ8c and GSK PERK inhibitor D3, which inhibit IRE1α RNAse activity and PERK 259 
activation respectively [26]. To confirm that 4µ8c and GSK PERK inhibitor D3 blocked the 260 
relevant ER stress pathways, we analysed CHOP expression (figure 4B) and XBP-1 splicing 261 
(figure 4C) as readouts of PERK or IRE1α RNAse activity respectively, in response to 262 
tunicamycin stimulation. As expected, stimulation of mDC with tunicamycin potently induced 263 
expression of CHOP and XBP-1 splicing that was almost entirely blocked by the specific 264 
inhibitors. We next examined PKR phosphorylation in response to thapsigargin stimulation in 265 
the presence of 4µ8c or GSK PERK inhibitor D3 (figure 4D). Interestingly PKR 266 
phosphorylation was completely blocked by 4µ8c but only partially by GSK PERK inhibitor 267 
D3, indicating that ER stress- induced PKR activation relied entirely on IRE1α RNAse 268 
activity and PERK activation to a lesser extent. 269 
FIG 4. 270 
 271 
 272 
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3.5 C. trachomatis infection of mDC induces TLR4-dependent and -independent ER stress 273 
responses 274 
We have previously reported that Chlamydia trachomatis infection of mDC induces 275 
activation of the Integrated Stress Response (ISR) resulting in CHOP expression that 276 
enhances inflammatory responses [12]. However, there are no published data investigating 277 
IRE1α activation in response to Chlamydia infection. We therefore investigated XBP-1 278 
splicing as an indicator of IRE1α activation in response to C. trachomatis infection (figure 279 
5A). Infection induced robust XBP-1 splicing that was inhibited by 4µ8c but not by GSK 280 
PERK inhibitor D3 demonstrating that C. trachomatis infection was causing activation of 281 
IRE1α RNAse activity. Furthermore, we found that Chlamydia infection-induced IRE1α 282 
activation was dependent on TLR4 signalling as XBP-1 splicing was reduced in the presence 283 
of a TLR4 blocking antibody, and similar results were obtained with LPS as a control (figure 284 
5C and figure 5D). We also confirmed that C. trachomatis infection induced CHOP 285 
expression in mDC, indicating activation of the ISR (figure 5E). Surprisingly, CHOP 286 
expression was independent of IRE1α and PERK activation as 4µ8c and GSK PERK inhibitor 287 
D3 had no effect on CHOP mRNA expression. Furthermore, Chlamydia infection- induced 288 
CHOP expression was independent of TLR4 signalling (figure 5F) as blocking TLR4 289 
signalling with the TLR4 blocking antibody, resulted in increased CHOP expression in 290 
response to C. trachomatis suggesting that induction of the ISR occurs independently of LPS 291 
and TLR4 and is therefore distinct to the activation of IRE1α and PKR. Mammalian cells also 292 
express two additional eIF2α kinases, namely GCN2 and HRI, which are activated in 293 
response to amino acid or heme depletion respectively [27]. Chlamydiae sp have been termed 294 
‘energy parasites’ as they utilise host cell metabolites such as amino acids [28]. Given that we 295 
have provided evidence that CHOP induction was independent of PERK and TLR4 induced 296 
PKR activation, we tested the hypothesis that CHOP induction in response to Chlamydia 297 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 13
infection occurs through activation of the amino acid responsive eIF2α kinase GCN2. To do 298 
this, we infected wild type (gcn2+/+) or GCN2 knock out (gcn2-/-) MEF’s with C. trachomatis 299 
or the murine pathogen Chlamydia muridarum (that induces a more potent CHOP response 300 
than C. trachomatis in MEF’s) and examined CHOP expression (figure 5G). Interestingly, 301 
induction of CHOP expression by C. trachomatis or C. muridarum infection was entirely 302 
GCN2 dependent indicating that although infection resulted in PKR activation, GCN2 is the 303 
likely eIF2α kinase responsible for the induction of the ISR and is independent of IRE1α, 304 
PKR, PERK and TLR4 signalling. 305 
FIG 5. 306 
3.6 TLR4/IRE1α signalling mediates PKR activation and is required for enhancement of type-307 
1 interferon in response to C. trachomatis infection 308 
We have demonstrated that ER stress induced PKR activation was inhibited by 4µ8C 309 
suggesting that PKR activation in response to ER-stress requires IRE1α RNAse activity. 310 
Furthermore, we have shown that C. trachomatis infection or LPS stimulation resulted in 311 
potent PKR phosphorylation that was TLR4 dependent and independent of NADPH oxidase. 312 
Lastly, we provided evidence that infection or LPS stimulation results in the activation of 313 
IRE1α that is also TLR4 dependent. We therefore tested the hypothesis that infection- and 314 
LPS- induced PKR phosphorylation occurs as a consequence of IRE1α RNAse activity. To do 315 
this we infected mDC with C. trachomatis (figure 6A) or stimulated with LPS (figure 6B) in 316 
the presence of 4µ8c or GSK PERK inhibitor D3. Importantly 4µ8c, but not GSK PERK 317 
inhibitor D3, potently blocked both C. trachomatis- and LPS-induced PKR activation. These 318 
data are suggestive of a novel, universal mechanism for the activation of PKR during non-319 
viral infection, in the absence of viral dsRNA, such as occurs during bacterial infection. 320 
Finally, we wished to address a role for PKR during Chlamydia infection. Previous reports 321 
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have demonstrated that PKR activation in response to TLR4 stimulation is required for the 322 
enhancement of type-1 interferon production [6]. Given that we observed an apparent 323 
redundancy for PKR in the activation of the integrated stress response, we hypothesised that 324 
PKR may play an alternative inflammatory role in response to Chlmaydia infection. 325 
Importantly, 4µ8c and the specific PKR inhibitor-C16 (PKRi), significantly reduced 326 
interferon-β transcription in mDC, while the PERK inhibitor (that did not affect PKR 327 
activation) had no effect (figure 6C). This suggests that TLR4/IRE1α mediated PKR 328 
activation enhances type-1 interferon response following Chlamydia infection and indicates 329 
that the role of PKR during infection is one of regulating inflammatory, rather than 330 
translational responses. To confirm our results in human mDC, we infected PKR wild type 331 
and PKR knock-out BMDM with C. trachomatis and analysed interferon-β secretion (figure 332 
6D). Crucially, PKR deficient BMDM showed reduced interferon secretion in response to 333 
infection than the wild-type cells reinforcing our data using mDC. 334 
FIG 6. 335 
 336 
4. Conclusions 337 
In this study we have demonstrated that infection of monocyte-derived DC with C. 338 
trachomatis or stimulation with LPS results in TLR4-dependent activation of the IRE1α 339 
branch of the UPR, and that an inhibitor of IRE1α RNAse activity blocks PKR 340 
phosphorylation. Furthermore, inducing ER stress in mDC also resulted in PKR 341 
phosphorylation that was dependent on IRE1a RNAse activity. Taken together, these data 342 
suggest a universal mechanism of PKR activation by TLR signalling in the absence of dsRNA. 343 
A possible explanation for the central role for IRE1α  is that host mRNAs, processed by 344 
IRE1α-through Regulated IRE1α Dependent Decay (RIDD) [29], may provide RNA 345 
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structures that are recognised by PKR as damage associated molecular patterns (DAMP’s). In 346 
support of this hypothesis, RIDD processed mRNA can act as a DAMP by activating the 347 
cytosolic PRR, RIG-1 [30]. It is therefore tempting to speculate that a similar process may 348 
occur during C. trachomatis infection resulting in PKR activation through detection of host 349 
degraded mRNA, possibly through interactions with RIG-1. Alternatively, a recent report has 350 
suggested that small nucleolar RNA (snoRNA) are capable of activating PKR in response to 351 
metabolic stress induced by palmitic acid [31]. Furthermore, it has been demonstrated that 352 
PKR phosphorylation in response to thapsigargin or palmitic acid stimulation relies upon a 353 
functional dsRNA binding domain in PKR [10]. Again, we suggest these previous findings 354 
support our hypothesis that PKR activation in response to TLR4 stimulation or infection is 355 
occurring through detection of host RNA species that are induced or modified through IRE1α 356 
RNAse activity. In further support of this hypothesis, the inhibitor 4µ8C, does not affect the 357 
kinase activity of IRE1α, but functions by forming a Schiff base with a critical lysine residue 358 
within the endonuclease domain of IRE1α. [32].  359 
Interestingly, we found that C. trachomatis induced PKR activation utilised MyD88 as an 360 
adaptor while we found in accordance with other reports, that E. coli derived LPS utilised 361 
TRIF [6]. This finding is surprising given that C. trachomatis is an intracellular pathogen and 362 
MyD88 signalling is thought to integrate TLR4 signals originating from the plasma 363 
membrane, while TRIF is utilised by TLR4 signalling from endosomal compartments [33]. 364 
This suggests that MyD88 may have a role during intracellular bacterial infection signalling 365 
from endosomal compartments leading to PKR activation. A further explanation for the 366 
difference in adaptor use between C. trachomatis and E. coli LPS is the structure of the lipid 367 
A moieties.  Lipid A from C. trachomatis is penta-acylated while E. coli lipid A is hexa-368 
acylated. Recent evidence has demonstrated that in comparison to hexa-acylated LPS, penta-369 
acylated LPS induces weak TLR4 signalling as it does not induce TLR4 dimerisation and 370 
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endocytosis. Furthermore, penta-acylated LPS can inhibit hexa-acylated LPS induced TRIF 371 
responses but maintain myddosome formation [34]. This finding may explain TLR4 reliance 372 
on MyD88 and not TRIF as an adaptor in response to C. trachomatis infection to induce PKR 373 
activation. To our knowledge there are no published studies investigating the lipid A acylation 374 
status of LPS and PKR activation. Studies have shown that the acylation status of lipid A is 375 
crucial for determining activation of inflammatory responses [35], therefore investigating 376 
whether acylation status of lipid A determines adaptor usage during TLR4 induced PKR 377 
activation would be worthwhile. Importantly, other reports have demonstrated MyD88 378 
signalling is the predominant adaptor protein involved in Chlamydia species-induced 379 
inflammatory responses and our data compliment these previous findings [36-37].  380 
Infection induced PKR activation did not require NADPH oxidase, in contrast to cholesterol 381 
loading induced PKR activation [9]. However, other cellular sources of ROS have been 382 
identified, notably mitochondrial-derived ROS that have been demonstrated to be a key 383 
component of the innate inflammatory response in myeloid cells [38-39]. Furthermore, 384 
mitochondrial derived ROS have been implicated in PKR activation [7]. Although we have 385 
demonstrated that NADPH oxidase and likely, NADPH oxidase derived ROS are dispensable 386 
for Chlamydia induced PKR activation, we cannot entirely rule out a role for ROS produced 387 
from alternate sources such as the mitochondria. 388 
We also report the interesting, but paradoxical observation that activation of the integrated 389 
stress response (ISR) resulting in CHOP expression as a consequence of Chlamydia infection 390 
was independent of TLR4 and by extension, the eIF2α kinase PKR. This observation is 391 
supported by evidence that demonstrates that TLR4 signalling actually suppresses activation 392 
of the ISR [40]. However, despite TLR4 suppression, C. trachomatis infection still resulted in 393 
CHOP expression, indicating activity of another eIF2α kinase that was distinct from 394 
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TLR4/IRE1α mediated PKR activation. Significantly, inhibition of PERK also failed to 395 
prevent Chlamydia-induced CHOP expression, indicating that another eIF2α kinase distinct 396 
from PERK or PKR was responsible. Mammalian cells possess the eIF2α kinases GCN2 and 397 
HRI in addition to PERK and PKR. GCN2 responds to amino acid starvation and represents a 398 
highly conserved mechanism of nutrient sensing. Using GCN2 deficient MEF’s we have 399 
demonstrated that induction of the ISR by Chlamydia infection was dependent on GCN2, 400 
suggesting that Chlamydiae induce an amino acid-deprived state within the infected host cell. 401 
Chlamydiae sp are known to utilise host cell amino acids [41-42] and this could potentially 402 
lead to depletion of intracellular amino acid levels leading to GCN2 activation. However, 403 
given that our experiments were carried out using cell growth medium that has excess 404 
concentrations of amino acids, Chlamydial depletion of host amino acids through metabolism 405 
appears unlikely. An alternative possibility is suggested by the observation that, intracellular 406 
infection with Shigella flexneri   induces host cell membrane damage that results in activation 407 
of GCN2 through amino acid depletion via an undefined mechanism [43]. Chlamydiae 408 
replicate intracellularly within a membrane bound parasitophorous vacuole termed the 409 
inclusion [44]. Recent work has demonstrated that the inclusion membrane is attacked during 410 
infection by host GTPases leading to membrane damage and the induction of antimicrobial 411 
autophagy responses [45]. Therefore, GTPase-induced membrane damage during Chlamydia 412 
infection could lead to GCN2 responses via a similar mechanism to that identified during 413 
Shigella infection. A further possibility is that  Chlamydia infection results in reduced 414 
tryptophan concentrations intracellularly, as a consequence of catabolic metabolism of 415 
tryptophan by the enzyme, Indoleamine 2,3-dioxygenase (IDO) [46]. Reduced tryptophan 416 
concentrations secondary to host responses could therefore drive activation of GCN2 and the 417 
ISR.  We have previously demonstrated a pro-inflammatory role for CHOP during C. 418 
trachomatis infection, enhancing IL-23 production; this required live, replicating Chlamydia 419 
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[12]. Thus the role of GCN2 responses in the induction of CHOP and its consequences for 420 
cytokine responses represents an intriguing line of enquiry. Additionally, further investigation 421 
is required to understand why PKR- despite it being potently activation by TLR4 signalling, is 422 
not required for ISR activation through its eIF2α kinase activity? We have provided evidence 423 
that PKR contributes to the enhancement of inflammatory responses as a consequence of 424 
TLR4 activation and suggests a potential dual role for PKR as either an eIF2α kinase or an 425 
inflammatory mediator depending on its activatory signal. 426 
Finally, using PKR deficient BMDM and inhibitors which block PKR activation, we have 427 
demonstrated that PKR activation contributes to type-1 interferon production in response to C. 428 
trachomatis infection. PKR has previously been reported to contribute to the induction of 429 
interferon-β transcription during TLR4 stimulation of macrophages [6] and our findings with 430 
Chlamydia infection are in agreement with this. Crucially, we also find that 4µ8c which 431 
blocked PKR activation in mDC, also reduced transcription of interferon-β to a similar extent 432 
as the specific PKR inhibitor C16 (PKRi) thereby reinforcing our findings that IRE-1α 433 
RNAse activity contributes to PKR activation and subsequent PKR mediated responses. 434 
In summary we have demonstrated a novel mechanism of PKR activation in response to 435 
Chlamydia infection, which requires TLR4 and IRE1α and that PKR enhances inflammatory 436 
responses. We have also demonstrated that activation of the ISR following Chlamydia 437 
infection occurs through the eIF2α kinase GCN2, presumably due to reduced amino acid 438 
availability, and is independent of TLR4, IRE1α, PKR and PERK. We therefore suggest that 439 
TLR4 activation of IRE1α RNAse activity, results in the production of modified host RNA 440 
species which are detected by PKR, leading to its activation. These data provide an attractive 441 
explanation for the activation of PKR during bacterial infections in the absence of viral 442 
dsRNA.  443 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 19
Acknowledgements 444 
We thank Professor David Ron at the University of Cambridge for providing us with the wild 445 
type and GCN2 knock out MEF’s. We are extremely grateful to Mike Bacon for excellent 446 
technical assistance and we would like to thank Sarita Workman at the Royal Free Hospital 447 
London, for her assistance in providing the CGD patient samples. This work was supported 448 
by an MRC grant to JCG and JSHG, an Arthritis Research Senior Fellowship grant to JCG, 449 
the NIHR Cambridge Biomedical Research Centre and Cambridge Arthritis Research 450 
Endeavour (CARE). 451 
 452 
Conflict of interest 453 
All authors confirm there are no conflicts of interest. 454 
 455 
 References 456 
 457 
[1] Levin D, London IM. Regulation of protein synthesis: activation by double-stranded RNA 458 
of a protein kinase that phosphorylates eukaryotic initiation factor 2. Proc Natl Acad Sci U S 459 
A 1978;75:1121-5. 460 
[2] Meurs E, Chong K, Galabru J, Thomas NS, Kerr IM, Williams BR, et al. Molecular 461 
cloning and characterization of the human double-stranded RNA-activated protein kinase 462 
induced by interferon. Cell 1990;62:379-90. 463 
[3] Clemens MJ. PKR--a protein kinase regulated by double-stranded RNA. Int J Biochem 464 
Cell Biol 1997;29:945-9. 465 
[4] Romano PR, Garcia-Barrio MT, Zhang X, Wang Q, Taylor DR, Zhang F, et al. 466 
Autophosphorylation in the activation loop is required for full kinase activity in vivo of 467 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 20
human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2. Mol Cell Biol 468 
1998;18:2282-97. 469 
[5] Cabanski M, Steinmuller M, Marsh LM, Surdziel E, Seeger W, Lohmeyer J. PKR 470 
regulates TLR2/TLR4-dependent signaling in murine alveolar macrophages. Am J Respir 471 
Cell Mol Biol 2008;38:26-31. 472 
[6] Hsu LC, Park JM, Zhang K, Luo JL, Maeda S, Kaufman RJ, et al. The protein kinase PKR 473 
is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 474 
2004;428:341-5. 475 
[7] Lu B, Nakamura T, Inouye K, Li J, Tang Y, Lundback P, et al. Novel role of PKR in 476 
inflammasome activation and HMGB1 release. Nature 2012;488:670-4. 477 
[8] He Y, Franchi L, Nunez G. The protein kinase PKR is critical for LPS-induced iNOS 478 
production but dispensable for inflammasome activation in macrophages. Eur J Immunol 479 
2013;43:1147-52. 480 
[9] Li G, Scull C, Ozcan L, Tabas I. NADPH oxidase links endoplasmic reticulum stress, 481 
oxidative stress, and PKR activation to induce apoptosis. J Cell Biol 2010;191:1113-25. 482 
[10] Nakamura T, Furuhashi M, Li P, Cao H, Tuncman G, Sonenberg N, et al. Double-483 
stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic 484 
homeostasis. Cell 2010;140:338-48. 485 
[11] Singh M, Fowlkes V, Handy I, Patel CV, Patel RC. Essential role of PACT-mediated 486 
PKR activation in tunicamycin-induced apoptosis. J Mol Biol 2009;385:457-68. 487 
[12] Goodall JC, Wu C, Zhang Y, McNeill L, Ellis L, Saudek V, et al. Endoplasmic reticulum 488 
stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression. Proc 489 
Natl Acad Sci U S A 2010;107:17698-703. 490 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 21
[13] Bulut Y, Faure E, Thomas L, Karahashi H, Michelsen KS, Equils O, et al. Chlamydial 491 
heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 492 
and MD2 in a MyD88-dependent pathway. J Immunol 2002;168:1435-40. 493 
[14] Joyee AG, Yang X. Role of toll-like receptors in immune responses to chlamydial 494 
infections. Curr Pharm Des 2008;14:593-600. 495 
[15] Shimada K, Crother TR, Karlin J, Chen S, Chiba N, Ramanujan VK, et al. Caspase-1 496 
dependent IL-1beta secretion is critical for host defense in a mouse model of Chlamydia 497 
pneumoniae lung infection. PLoS One 2011;6:e21477. 498 
[16] O'Connell CM, Ionova IA, Quayle AJ, Visintin A, Ingalls RR. Localization of TLR2 and 499 
MyD88 to Chlamydia trachomatis inclusions. Evidence for signaling by intracellular TLR2 500 
during infection with an obligate intracellular pathogen. J Biol Chem 2006;281:1652-9. 501 
[17] Romano Carratelli C, Mazzola N, Paolillo R, Sorrentino S, Rizzo A. Toll-like receptor-4 502 
(TLR4) mediates human beta-defensin-2 (HBD-2) induction in response to Chlamydia 503 
pneumoniae in mononuclear cells. FEMS Immunol Med Microbiol 2009;57:116-24. 504 
[18] Nurminen M, Rietschel ET, Brade H. Chemical characterization of Chlamydia 505 
trachomatis lipopolysaccharide. Infect Immun 1985;48:573-5. 506 
[19] Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-507 
deficient mice to endotoxin. Immunity 1999;11:115-22. 508 
[20] Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, et al. Identification of Lps2 as 509 
a key transducer of MyD88-independent TIR signalling. Nature 2003;424:743-8. 510 
[21] Baehner RL, Nathan DG. Leukocyte oxidase: defective activity in chronic 511 
granulomatous disease. Science 1967;155:835-6. 512 
[22] Segal BH, Grimm MJ, Khan AN, Han W, Blackwell TS. Regulation of innate immunity 513 
by NADPH oxidase. Free Radic Biol Med 2012;53:72-80. 514 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 22
[23] Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein 515 
response. Nat Rev Mol Cell Biol 2007;8:519-29. 516 
[24] Martinon F, Chen X, Lee AH, Glimcher LH. TLR activation of the transcription factor 517 
XBP1 regulates innate immune responses in macrophages. Nat Immunol 2010;11:411-8. 518 
[25] Smith JA, Turner MJ, DeLay ML, Klenk EI, Sowders DP, Colbert RA. Endoplasmic 519 
reticulum stress and the unfolded protein response are linked to synergistic IFN-beta 520 
induction via X-box binding protein 1. Eur J Immunol 2008;38:1194-203. 521 
[26] Hetz C, Chevet E, Harding HP. Targeting the unfolded protein response in disease. Nat 522 
Rev Drug Discov 2013;12:703-19. 523 
[27] Wek RC, Jiang HY, Anthony TG. Coping with stress: eIF2 kinases and translational 524 
control. Biochem Soc Trans 2006;34:7-11. 525 
[28] Kuo CC, Grayston JT. Amino acid requirements for growth of Chlamydia pneumoniae in 526 
cell cultures: growth enhancement by lysine or methionine depletion. J Clin Microbiol 527 
1990;28:1098-100. 528 
[29] Maurel M, Chevet E, Tavernier J, Gerlo S. Getting RIDD of RNA: IRE1 in cell fate 529 
regulation. Trends Biochem Sci 2014;39:245-54. 530 
[30] Cho JA, Lee AH, Platzer B, Cross BCS, Gardner BM, De Luca H, et al. The Unfolded 531 
Protein Response Element IRE1 alpha Senses Bacterial Proteins Invading the ER to Activate 532 
RIG-I and Innate Immune Signaling. Cell Host Microbe 2013;13:558-69. 533 
[31] Youssef OA, Safran SA, Nakamura T, Nix DA, Hotamisligil GS, Bass BL. Potential role 534 
for snoRNAs in PKR activation during metabolic stress. Proc Natl Acad Sci U S A 535 
2015;112:5023-8. 536 
[32] Cross BC, Bond PJ, Sadowski PG, Jha BK, Zak J, Goodman JM, et al. The molecular 537 
basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small 538 
molecule. Proc Natl Acad Sci U S A 2012;109:E869-78. 539 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 23
[33] Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. TRAM couples endocytosis 540 
of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 2008;9:361-8. 541 
[34] Tan Y, Zanoni, I, Cullen, TW, Goodman, AL, Kagan, JC. Mechanisms of toll-like 542 
receptor 4 endocytosis reveal a common immune-evasion strategy used by pathogenic and 543 
commensal bacteria. Immunity 2015;43:1-14. 544 
[35] Maeshima N, Fernandez RC. Recognition of lipid A variants by the TLR4-MD-2 545 
receptor complex. Front Cell Infect Microbiol 2013;3:3. 546 
[36] Naiki Y, Michelsen KS, Schroder NW, Alsabeh R, Slepenkin A, Zhang W, et al. MyD88 547 
is pivotal for the early inflammatory response and subsequent bacterial clearance and survival 548 
in a mouse model of Chlamydia pneumoniae pneumonia. J Biol Chem 2005;280:29242-9. 549 
[37] Zhang X, Gao L, Lei L, Zhong Y, Dube P, Berton MT, et al. A MyD88-dependent early 550 
IL-17 production protects mice against airway infection with the obligate intracellular 551 
pathogen Chlamydia muridarum. J Immunol 2009;183:1291-300. 552 
[38] Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 553 
inflammasome activation. Nature 2011;469:221-5. 554 
[39] Bulua AC, Simon A, Maddipati R, Pelletier M, Park H, Kim KY, et al. Mitochondrial 555 
reactive oxygen species promote production of proinflammatory cytokines and are elevated in 556 
TNFR1-associated periodic syndrome (TRAPS). J Exp Med 2011;208:519-33. 557 
[40] Woo CW, Kutzler L, Kimball SR, Tabas I. Toll-like receptor activation suppresses ER 558 
stress factor CHOP and translation inhibition through activation of eIF2B. Nat Cell Biol 559 
2012;14:192-200. 560 
[41] Braun PR, Al-Younes H, Gussmann J, Klein J, Schneider E, Meyer TF. Competitive 561 
inhibition of amino acid uptake suppresses chlamydial growth: involvement of the chlamydial 562 
amino acid transporter BrnQ. J Bacteriol 2008;190:1822-30. 563 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 24
[42] Harper A, Pogson CI, Jones ML, Pearce JH. Chlamydial development is adversely 564 
affected by minor changes in amino acid supply, blood plasma amino acid levels, and glucose 565 
deprivation. Infect Immun 2000;68:1457-64. 566 
[43] Tattoli I, Sorbara MT, Vuckovic D, Ling A, Soares F, Carneiro LA, et al. Amino acid 567 
starvation induced by invasive bacterial pathogens triggers an innate host defense program. 568 
Cell Host Microbe 2012;11:563-75. 569 
[44] Fields KA, Hackstadt T. The chlamydial inclusion: escape from the endocytic pathway. 570 
Annu Rev Cell Dev Biol 2002;18:221-45. 571 
[45] Al-Zeer MA, Al-Younes HM, Lauster D, Abu Lubad M, Meyer TF. Autophagy restricts 572 
Chlamydia trachomatis growth in human macrophages via IFNG-inducible guanylate binding 573 
proteins. Autophagy 2013;9:50-62. 574 
[46] Beatty WL, Belanger TA, Desai AA, Morrison RP, Byrne GI. Tryptophan depletion as a 575 
mechanism of gamma interferon-mediated chlamydial persistence. Infect Immun 576 
1994;62:3705-11. 577 
 578 
 579 
 580 
 581 
 582 
 583 
 584 
 585 
 586 
 587 
 588 
 589 
 590 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 25
Figure captions 591 
 592 
Figure 1. Chlamydia trachomatis induces PKR activation in mDC  593 
(A) Western blot of PKR phosphorylation following stimulation with indicated PRR agonists 594 
for 4hrs. Panel below indicates quantification by densitometry of the phosphorylated PKR 595 
band. (B) Western blot of PKR phosphorylation (pPKR) following infection with C. 596 
trachomatis for 8hrs at different multiplicities of infection (MOI). (C) Western blot of PKR 597 
phosphorylation (pPKR) following stimulation with live C. trachomatis (CT), gamma ray -598 
attenuated C. trachomatis (γ-CT), heat-treated C. trachomatis, LPS or heat-treated LPS for 599 
8hrs. Right panel indicates by densitometry of the phosphorylated PKR band. 600 
 601 
Figure 2. Chlamydia trachomatis induces PKR activation via TLR4 and MyD88 602 
signalling 603 
(A) Western blot of PKR phosphorylation (pPKR) following infection with C. trachomatis 604 
(MOI=20) for 4hrs in the presence of lipid IVa (1µg/ml) or TLR4 blocking antibody (αTLR4) 605 
(10µg/ml). (B) Western blot of PKR phosphorylation (pPKR) following LPS stimulation 606 
(1µg/ml) for 4hrs in the presence of lipid IVa (1µg/ml) or TLR4 blocking antibody (αTLR4) 607 
(10µg/ml). (C) Western blot of PKR phosphorylation (pPKR) following infection with C. 608 
trachomatis (MOI=20) for 4hrs in the presence of (50µM) control peptide (CP), TRIF 609 
inhibitory peptide (TRIFi) or MyD88 inhibitory peptide (MyD88i). (D) Western blot of PKR 610 
(pPKR) phosphorylation following LPS stimulation (1µg/ml) for 4hrs in the presence of 611 
(50µM) control peptide (CP), TRIF inhibitory peptide (TRIFi) or MyD88 inhibitory peptide 612 
(MyD88i). Panels below western blots indicate quantification by densitometry of the 613 
phosphorylated PKR band. * denotes non specific band. 614 
 615 
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Figure 3. PKR activation is independent of NADPH oxidase and mitochondrial derived 616 
reactive oxygen species 617 
(A) Western blot of PKR phosphorylation (pPKR) in wild type (cybb+/+) or NADPH oxidase-618 
deficient (cybb-/-) BMDM following infection with C. trachomatis for 8hrs. Panel on the right 619 
indicates quantification by densitometry of the phosphorylated PKR band. (B) Western blot of 620 
PKR (pPKR) phosphorylation in mDC from a healthy donor or a CGD donor following 621 
infection with C. trachomatis for 6hrs. Panel on the right indicates quantification by 622 
densitometry of the phosphorylated PKR band. 623 
 624 
Figure 4. ER stress activates PKR that is blocked by an inhibitor of IRE1α RNAse 625 
activity 626 
(A) Western blot of PKR phosphorylation (pPKR) in mDC following stimulation with 627 
Tunicamycin (1µM) or Thapsigargin (0.25µM) for indicated times. (B) CHOP mRNA 628 
expression in mDC following stimulation with tunicamycin (1µM) for 4hrs in the presence of 629 
GSK PERK inhibitor D3 (PERKi) (1µM) n=4 independent donors ***p=<0.001. Data 630 
represented as ± SEM. (C) XBP-1 splicing in mDC following stimulation with tunicamycin 631 
(1µM) for 4hrs in the presence of 4µ8C (30µM) n=4 independent donors  ***p=<0.001. Data 632 
represented as ± SEM. (D) Western blot of PKR phosphorylation (pPKR) in mDC following 633 
stimulation with thapsigargin (0.25µM) for 6hrs in the presence of 4µ8C (30µM) or GSK 634 
PERK inhibitor D3 (PERKi) (1µM). Panel below indicates quantification by densitometry of 635 
the phosphorylated PKR band.  * denotes non specific band. 636 
 637 
 638 
 639 
 640 
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Figure 5. Chlamydia infection activates ER stress pathways that are dependent and 641 
independent of TLR4 signalling 642 
(A) XBP-1 splicing in mDC following infection with C. trachomatis (CT) MOI=20 for 4hrs 643 
in the presence of 4µ8C (30µM) or GSK PERK inhibitor D3 (PERKi) (1µM) n=4 independent 644 
donors **p=<0.01. Data represented as ± SEM. (B) XBP-1 splicing in mDC following 645 
infection with C. trachomatis (CT) MOI=20 in the presence of a TLR4 blocking antibody 646 
(αTLR4) (10µg/ml) n=4 independent donors *p=<0.05. (C) XBP-1 splicing in mDC following 647 
LPS stimulation (1µg/ml) for 4hrs in the presence of 4µ8C (30µM) or GSK PERK inhibitor 648 
D3 (PERKi) (1µM) n=4 independent donors **p=<0.01. Data represented as ± SEM. (D) 649 
XBP-1 splicing in mDC following LPS stimulation (1µg/ml) for 4hrs in the presence of a 650 
TLR4 blocking antibody (αTLR4) (10µg/ml) n=6 independent donors **p=<0.01. (E) CHOP 651 
mRNA expression in mDC following infection with C. trachomatis (CT) MOI=20 for 4hrs in 652 
the presence of 4µ8C (30µM) or GSK PERK inhibitor D3 (PERKi) (1µM) n=4 independent 653 
donors.  Data represented as ± SEM. (F) CHOP mRNA expression in mDC following 654 
infection with C. trachomatis (CT) MOI=20 for 24hrs in the presence of a TLR4 blocking 655 
antibody (αTLR4) (10µg/ml). Data represented as ± SEM from 1 experiment performed in 656 
triplicate wells ***p=<0.001. (G) CHOP mRNA expression in wild type (gcn2+/+) or GCN2 657 
knock out (gcn2-/-) MEF’s following infection with C. trachomatis or C. muridarum (CM) 658 
MOI=10 for 24hrs. Data represented as ± SEM from 1 experiment performed in triplicate 659 
wells ***p=<0.001. 660 
 661 
 662 
 663 
 664 
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Figure 6. TLR4 induced PKR activation is blocked by an inhibitor of IRE1α RNAse 665 
activity but not PERK phosphorylation and is required for enhancement of Interferon-β 666 
production 667 
(A) Western blot of PKR phosphorylation (pPKR) following infection with C. trachomatis 668 
(MOI=20) for 4hrs in the presence of 4µ8C (30µM) or GSK PERK inhibitor D3 (PERKi) 669 
(1µM). Panel on the right indicates quantification by densitometry of the phosphorylated PKR 670 
band. (B) Western blot of PKR phosphorylation (pPKR) following LPS stimulation (1µg/ml) 671 
for 4hrs in the presence of 4µ8C (30µM) or GSK PERK inhibitor D3 (PERKi) (1µM). * 672 
denotes non-specific band. Panel on the right indicates quantification by densitometry of the 673 
phosphorylated PKR band. (C) Interferon-β mRNA expression in mDC following infection 674 
with C. trachomatis (CT) MOI=20 for 8hrs in the presence of 4µ8C (30µM), PKR inhibitor 675 
C16 (PKRi) (500nM) or the GSK PERK inhibitor D3 (PERKi) (1µM). Data represented as ± 676 
SEM from 1 experiment performed in triplicate wells ***p=<0.001.  Right panel depicts 677 
western blot of PKR phosphorylation (pPKR) in mDC in response to C. trachomatis infection 678 
for 4hrs in the presence of the PKR inhibitor C16 (PKRi) (500nM). (D) ELISA of interferon-β 679 
secretion (U/ml) in supernatants from wild type (PKR+/+) or PKR knock-out (PKR-/-) BMDM 680 
infected with C. trachomatis (CT) MOI=20 for 24hrs. Data represented as ± SEM from 1 681 
experiment performed using BMDM obtained from three separate individual wild type or 682 
knock out mice ***p=<0.001. (E) Schematic representation of pathways activated in response 683 
to C. trachomatis infection. 684 
 685 
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